Home / Stocks / Themis Medicare Ltd.
THEMISMED

Themis Medicare Ltd. Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹96.98

Change

+0.48 (0.5%)

Open

₹96.92

Prev. Close

₹96.5

Day High

₹98.0

Day Low

₹96.2

Volume Analysis

Traded

19,850

Delivered

13,444

Delivery %

67.73%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (3)

  • •Low return on equity (0.41%)
  • •Below-average fundamentals quality score (39/100)
  • •Low operating margin (-13.0%)

Opportunities (0)

No signal for this stock

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹99.72 ₹98.86 ₹97.92 ₹97.06 ₹96.12 ₹95.26 ₹94.32
Fibonacci ₹98.86 ₹98.17 ₹97.75 ₹97.06 ₹96.37 ₹95.95 ₹95.26
Camarilla ₹97.48 ₹97.31 ₹97.15 ₹97.06 ₹96.82 ₹96.65 ₹96.49

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-2.85%

1 Week

-4.98%

1 Month

+1.14%

3 Months

-8.63%

6 Months

-3.3%

1 Year

-13.8%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹10.81

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

10.3%

Net margin 12.05% × asset turnover 0.57x × equity multiplier 1.5x

Company Overview

Sector

Healthcare

Market Cap

₹929 Cr

P/E (TTM)

624.0

ROE

0.41%

Book Value

₹43.3

Face Value

₹1.0

Source: Screener.in (Consolidated figures) — data as of 15 Nov 2026. Not investment advice.

TopFund Analysis

Themis Medicare Ltd. scores weakly on TopFund's composite fundamentals check within the Healthcare sector, at 39/100. The strongest factor is Financial Strength (100/100), while Cash Flow (0/100) is the weakest area to weigh before deciding. Notably: Low return on equity (0.41%); below-average fundamentals quality score (39/100).

TopFund Score — Fundamentals Quality

39/100 — Weak

Data confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

100

Growth

10

Valuation

27

Cash Flow

0

Corporate Governance

56

Momentum

47

Institutional Ownership

30

Business Quality

34

Risk & Volatility

30

Liquidity

47

From Screener.in

  • +Company has been maintaining a healthy dividend payout of 143%
  • −Company has low interest coverage ratio.
  • −The company has delivered a poor sales growth of 8.21% over past five years.
  • −Company has a low return on equity of 6.41% over last 3 years.
  • −Promoters have pledged 45.8% of their holding.

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Sales + 97 105 83 98 123 117 94 72 98 78 90 77 87
Expenses + 75 92 74 89 94 100 88 79 108 81 80 73 139
Operating Profit 22 12 8 9 29 17 6 -8 -10 -3 10 4 -52
OPM % 22.0% 12.0% 10.0% 10.0% 24.0% 15.0% 6.0% -11.0% -10.0% -4.0% 11.0% 4.9% -60.0%
Other Income + 6 7 6 5 7 6 1 2 1 5 6 11 97
Interest 2 2 3 2 2 2 3 2 2 3 3 3 3
Depreciation 3 3 3 3 2 2 3 3 3 3 3 3 3
Profit before tax 23 14 8 9 31 18 2 -11 -14 -3 10 9 39
Tax % 19.0% 19.0% 10.0% 24.0% 21.0% 20.0% 69.0% -13.0% 1.0% 5.0% 3.0% 2.0% 36.0%
Net Profit + 18 11 7 7 25 14 1 -10 -14 -4 10 9 25
EPS in Rs 2 1 1 1 3 2 0 -1 -2 0 1 1 3
Raw PDF — — — — — — — — — — — — —
YoY Sales growth 2 15 -7 22 27 12 14 -27 -21 -33 -4 7 -11

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 202 232 217 210 184 202 231 395 354 382 406 342 332
Expenses + 184 194 184 184 181 166 181 299 287 330 356 342 374
Operating Profit 18 38 33 25 2 36 49 96 67 52 49 0 -42
OPM % 9.0% 16.0% 15.0% 12.0% 1.2% 18.0% 21.0% 24.0% 19.0% 13.0% 12.0% 0.1% -13.0%
Other Income + 13 3 4 6 5 12 13 18 25 24 11 23 118
Interest 15 12 12 12 12 13 13 9 10 9 10 11 11
Depreciation 11 12 7 7 8 8 9 9 10 12 10 10 10
Profit before tax 5 17 18 11 -13 27 41 95 73 53 40 2 55
Tax % -20.0% 11.0% 9.0% 1.0% -15.0% 8.0% 14.0% 23.0% 22.0% 19.0% 25.0% 40.0% —
Net Profit + 6 16 16 11 -11 25 36 73 57 44 30 1 40
EPS in Rs 1 2 2 1 -1 3 4 8 6 5 3 0 4
Dividend Payout % 25.0% 9.0% 0.0% 0.0% 0.0% 6.0% 11.0% 6.0% 8.0% 11.0% 15.0% 404.0% —
Sales growth 4 15 -7 -3 -12 10 14 71 -10 8 6 -16 -13

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Reserves 51 66 143 160 149 174 209 278 330 368 393 389
Borrowings + 140 128 82 80 82 100 87 80 92 96 83 100
Other Liabilities + 77 73 54 56 74 67 65 61 82 93 102 99
Total Liabilities 277 275 289 305 314 350 371 428 514 566 588 598
Fixed Assets + 122 117 124 126 123 116 133 144 162 168 172 167
CWIP 4 6 9 2 2 8 2 3 3 3 3 2
Investments 5 6 23 24 27 35 45 56 70 89 95 109
Other Assets + 146 146 133 153 162 191 191 225 279 307 318 320
Total Assets 277 275 289 305 314 350 371 428 514 566 588 598
Equity Capital 8 9 9 9 9 9 9 9 9 9 9 9

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 19 26 -2 8 11 0 57 34 16 22 35 -3
Cash from Investing Activity + -6 -7 -4 0 -4 -5 -16 -16 -24 -16 -12 -3
Cash from Financing Activity + -18 -13 5 -9 -10 7 -26 -18 0 -9 -26 4
Net Cash Flow -5 5 0 -1 -3 2 16 1 -8 -3 -3 -2
Free Cash Flow 13 18 -7 5 5 -5 39 15 -13 4 21 -8
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 101 73 -5 29 490 2 115 55 48 60 93 782

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 67.16% → 67.1%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 32.82% 32.81% 32.79% 32.74% 32.75% 32.7% 32.75% 32.77% 32.84% 32.78% 32.87% 32.87%
Promoters 67.16% 67.15% 67.15% 67.15% 67.15% 67.15% 67.15% 67.15% 67.1% 67.1% 67.1% 67.1%
FII 0.01% 0.03% 0.05% 0.1% 0.1% 0.14% 0.09% 0.06% 0.05% 0.11% 0.01% 0.01%
DII 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Themis Medicare Ltd. (this stock) 929 624.0 2.33 0.41%
Health X Platform Limited 862 510.0 1.36 0.44%
Lincoln Pharma Ltd 1,032 10.6 1.27 12.0%
Kilitch Drugs India Ltd 805 33.4 2.79 10.6%
Shree Ganesh Remedies Ltd 798 65.9 4.79 10.8%
Laxmi Dental Limited 1,076 29.7 4.05 14.8%
Sigachi Industries Ltd 1,088 41.3 2.02 5.78%

Which Mutual Funds Hold Themis Medicare Ltd.?

Frequently Asked Questions about Themis Medicare Ltd.

Community Sentiment

What are other investors saying about Themis Medicare Ltd.?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.